BioCentury
ARTICLE | Financial News

Oncodesign, Genomic Vision price French IPOs

April 3, 2014 12:46 AM UTC

Oncodesign S.A. (Euronext:ALONC) and Genomic Vision S.A. (Euronext:GV) both raised money in IPOs on Euronext Paris. Oncodesign raised EUR 12.2 million ($16.8 million) through the sale of 1.7 million new shares at EUR 7.34, which values Oncodesign at EUR 44.5 million ($61.2 million). CM-CIC Securities; LCM; and Arkeon were managers. Oncodesign is focused on drug discovery work for cancer compounds and has deals with UCB Group (Euronext:UCB), Sanofi (Euronext:SAN; NYSE:SNY) and Ipsen Group (Euronext:IPN).

Oncodesign was off EUR 0.55 to EUR 6.75 on its first day of trading Wednesday. ...